Health News

Crucell And Harvard To Test Experimental AIDS Vaccine In Uninfected Adults The pharmaceutical company Crucell, in collaboration with Harvard University, “plans to test its experimental AIDS vaccine in the U.S. and in Africa, advancing the quest for a protective shot against” HIV, Bloomberg reports…

Read more

Filed under: Pharmacy News
Tags: AIDS, Drug, HIV, Pharmacy

Related posts

• U-M scientists identify new reservoir for hidden HIV-infected cells that can serve as factory for new infections (0)
  University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for [...]
  
  
• Tenofovir gel reduces HIV by 39% in women: CAPRISA 004 study (0)
  Researchers who conducted a study testing a vaginal microbicide with an antiretroviral (ARV) drug called tenofovir found its use before and after sex was significantly more protective against HIV infection than a placebo gel among women at high risk of HIV. Results of the study, known as CAPRISA 004, are to be reported at the [...]
  
  
• Study: HIV treatment drugs slash transmission risk (0)
  AIDS researchers offered evidence backing up the long-standing idea that people infected with HIV who are being treated are much less likely to transmit the virus than those who are not on drugs. This finding is being hailed as a breakthrough. Read more [tags] Pharmacy News [/tags]
  
  
• Studies show AIDS drugs can prevent heterosexuals from acquiring HIV (0)
  Two new studies released early Wednesday show that AIDS drugs can prevent heterosexuals from acquiring HIV, adding to a growing number of new methods to slow the spread of the virus world-wide. Read more [tags] Pharmacy News [/tags]
  
  
• Scientists apply math model to HIV to discover targets for vaccines or drugs (0)
  Scientists at the Ragon Institute - a joint enterprise of Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University formed in 2009 to bring together diverse disciplines to work on HIV - "using a powerful mathematical tool previously applied to the stock market have identified an Achilles heel in HIV that could be [...]